Chromocell Corp. engages in the discovery and development of flavors and nutritional ingredients and therapeutic products. It specializes in different areas of taste sensations as well as aroma and fragrance enhancer discovery. The company was founded by Christian Kopfli and Kambiz Shekdar in 2002 and is headquartered in North Brunswick, NJ.

Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL.

Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.

Niulunjie Biomedical Technology (Suzhou) Co. Ltd. is a Chinese company that engages in research and development of gene therapy drugs.

BEMY Cosmetics uses unique mRNA technology to create a cosmetic skincare range.BEMY relies on decades of study and scientific experience to apply ethical, effective processes in its quest to become the world leader in personalized cosmetic technologies.

Shenzhen Zhende Keats Pharmaceutical Research and Development Co., Ltd., established on 2020-12-30, Business scope includes general business items:Technical research and development and sales of biological products;Domestic Trade;Import and export of goods and technology.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:none

Yulin Tech Biomedical Nantong Co., Ltd, established on 2015-06-12, Business scope includes licensed projects:Production of formula food for special medical purpose(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:R&D and application of cell technology;Human stem cell technology development and application;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Yunnan Keats Regenerative Medicine Research Institute Co., Ltd., established on 2018-01-08, Business scope includes research on stem cell biotechnology,Development and technology transfer;Stem Cell Storage Technology Services;stem cell collection,detection,to prepare,Freezing and Serving;immune cell technology,Research on Medical Testing Technology,to develop,technology transfer,technical consulting;medical service;Health Information Consultation,Business Management Consulting;cosmetic,Medical Device Research,development and production;Domestic Trade,Material supply and marketing;Genetic Testing Technology Consulting;Genetic data analysis service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ningbo Yisai Teng Biotechnology Co., Ltd., established on 2018-12-04, Business scope includes biotechnology,Biomedical Science,Technical development of pharmaceutical products,technical consulting,Technical Services,Technology transfer and related product sales;laboratory reagent,Consumables,Instrument sales;Own Equipment Rental Service;Exhibition display service;Corporate Event Planning;Self-operated and agent import and export of various goods and technologies,Except for goods and technologies that are restricted by the state or prohibited from import and export;and other legal,regulations,Projects that are not prohibited or do not require operating permits and projects that are not included in the negative list of local industrial development in the decision of the State Council.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Qilu Stem Cells Engineering Co. Ltd. operates a cord blood bank. The firm offers stem cell clinical research and technology development, and umbilical cord blood stem cell preservation services. The company was founded in July 2004 and is headquartered in Jinan, China.

Fluidigm Corporation is a biotechnology research agency that helps in improving health.

Hitachi Healthcare Manufacturing Ltd. manufactures medical instruments, analyzers, and medical information systems. The company was founded on May 9, 1949 and is headquartered in Kashiwa, Japan.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type. The platforms can be used to enhance existing stem-cell forward programming methods, or bypass development pathways altogether, affecting a direct transdifferentiation between a mature cell type to another mature cell type. Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease. Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications.

Zaikang Pharmaceutical Technology (Shanghai) Co., Ltd., established on 2016-07-25, The scope of business includes engaging in medical technology,medical technology,Biological Technology,Technology Transfer in the Field of Software Technology,technical consulting,technology development,Technical Services,drug development,medical instruments,Fitness Equipment,Sales of instrumentation,creative services,e-commerce(Not to engage in financial business),medical consultation,Nutrition and Health Consulting Services,Market information consultation and investigation(Do not engage in social investigation,social research,poll,opinion poll),Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Hangzhou Yisheng Medical Technology Co., Ltd., established on 2016-08-26, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Information Consulting Service(Not including licensing information consulting services);integrated circuit manufacturing;IC Design;IC sales;Integrated circuit chip and product manufacturing;Integrated circuit chip design and service;Integrated circuit chips and product sales;Manufacturing of Special Equipment for Semiconductor Devices;Professional Design Services;Electronic special material manufacturing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Technology Import and Export;Import and export;Drug import and export;Drug internet information service;Drug Wholesale;pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.